AI model sustains 30-hour focus on complex tasks

Anthropic announced that its latest artificial intelligence model maintained concentration for up to 30 hours while performing multi-step reasoning tasks, a leap beyond prior limits of hours or less. The model was tested on real-world challenges such as research synthesis, software debugging, and multi-document planning. Unlike earlier systems that drifted or repeated outputs, it consistently tracked context and goals. Researchers say the breakthrough lies in new attention-control techniques that reduce “forgetting” across long sequences. While this suggests strong potential for enterprise and scientific applications, questions remain about energy costs, misuse, and whether human oversight can keep pace with models operating continuously at scale. (Ars Technica)

Tech giants discuss routine releases for AI safety

Executives from Google, Meta, OpenAI, and other companies are debating whether to establish predictable release schedules for advanced AI models. The proposal would resemble periodic software updates, aiming to reduce the surprise factor of sudden rollouts and allow regulators, researchers, and the public to prepare for potential risks. Advocates say it could build trust and enable more robust oversight, while critics warn it might encourage adversaries to anticipate vulnerabilities or reduce competitive flexibility. The talks reflect mounting pressure on the industry to balance innovation with responsible deployment. Regulators in the U.S. and Europe are closely watching the discussions but no formal agreement has been reached. (New York Times)

Cannabis shows limited benefit for back pain

A study commissioned by a German medical cannabis company tested whether oral cannabis extract could reduce chronic low back pain. The double-blind, placebo-controlled trial involved about 100 patients over eight weeks. Results showed only a modest decrease in reported pain levels among those taking cannabis compared to placebo, with some participants experiencing side effects such as dizziness and nausea. Researchers concluded that while cannabis may provide relief for a small subset of patients, the overall effect size was limited. They emphasized the need for larger, independent studies before drawing firm conclusions about its role in pain management. The study was not conducted in the United States. (AP)

Scientists explain will-o’-the-wisps with microlightning

Researchers have proposed that the mysterious glowing orbs known as will-o’-the-wisps, long reported in marshes and folklore, may be caused by tiny lightning discharges. Laboratory experiments showed that when methane and other gases seep from decaying organic matter, they can generate localized electrical activity that produces faint, flickering blue light. This microlightning mechanism helps explain why the phenomenon is sporadic and often short-lived, matching historical accounts. The finding challenges older theories that blamed solely chemical combustion or ghostly folklore. Scientists hope to test the theory further in field studies by monitoring wetlands with sensitive light-detection instruments. (Science)

Unlocking the Venus flytrap’s hair-trigger mechanism

Scientists have uncovered how Venus flytraps detect and close on prey with such rapid precision. Each trigger hair on the trap contains specialized ion channels that convert mechanical touch into an electrical signal. Two touches within about 30 seconds generate enough charge to snap the trap shut, ensuring efficiency and reducing false alarms. Advanced imaging and electrophysiology revealed how calcium flows inside the plant’s cells to amplify the signal. The discovery provides new insights into plant sensory biology and could inspire bioengineered materials or robotics that mimic the flytrap’s responsive mechanics. Researchers see the work as a step toward linking plant neurobiology with applied technology. (Ars Technica)

Gene Therapy Slows Huntington’s Disease by 75 Percent in Groundbreaking Trial

A revolutionary gene therapy has demonstrated unprecedented success in slowing Huntington’s disease progression, offering hope for thousands affected by this fatal neurodegenerative disorder. The treatment, AMT-130, developed by uniQure, reduced disease progression by 75 percent over three years in patients receiving high doses compared to standard care. The therapy works by injecting a harmless virus containing custom DNA directly into the brain’s striatum, permanently instructing neurons to stop producing the toxic mutant huntingtin protein that causes the disease. Twenty-nine patients underwent complex neurosurgery for the trial, with twelve receiving high doses and showing remarkable stability. The treatment also reduced a key biomarker of neurodegeneration by 8.2 percent. Researchers call this a “world-changing” development, as no previous treatment has successfully slowed Huntington’s progression. UniQure plans to submit data to the FDA in early 2026 for potential approval. (UCL)

NASA Launches IMAP Mission to Map Solar System’s Protective Bubble

NASA successfully launched its Interstellar Mapping and Acceleration Probe on September 24, along with two companion spacecraft, aboard a SpaceX Falcon 9 rocket from Kennedy Space Center. The mission will study the heliosphere, a vast magnetic bubble created by solar wind that shields our solar system from galactic cosmic radiation and makes life on Earth possible. IMAP carries ten scientific instruments to map the heliosphere’s boundaries and sample particles streaming from the Sun and interstellar space. The spacecraft will travel to Lagrange point 1, approximately one million miles from Earth, arriving by January 2026. From this vantage point, IMAP will provide real-time space weather observations, delivering 30-minute advance warnings of dangerous solar radiation—crucial for protecting future Artemis astronauts and Mars missions. The mission also launched with NASA’s Carruthers Geocorona Observatory and NOAA’s space weather satellite. (NASA)

Clearest Black Hole Merger Signal Confirms Einstein and Hawking Predictions

Scientists detected the clearest gravitational wave signal ever recorded from colliding black holes, providing unprecedented confirmation of fundamental physics theories. The merger, designated GW250114, occurred on January 14, 2025, and was captured by LIGO with a signal-to-noise ratio of 80—nearly four times clearer than any previous detection. The collision involved two black holes approximately 33 times the Sun’s mass each, merging to create a 63-solar-mass black hole spinning at 100 revolutions per second. The exceptional clarity allowed researchers to observe the merger’s complete sequence, including the “ringdown” phase where the new black hole vibrates like a struck bell. This confirmed Stephen Hawking’s theory that black hole surface area never decreases during mergers and validated Albert Einstein’s predictions about space-time behavior. The breakthrough came ten years after LIGO’s first gravitational wave detection, with vastly improved technology enabling these precise measurements. (Science Daily)

Wastewater Treatment Plants Release Pharmaceutical Pollution into Waterways

Municipal wastewater treatment facilities are failing to remove common pharmaceuticals from sewage, releasing drugs like Prozac directly into rivers and streams where they threaten aquatic ecosystems. Researchers from Poland’s Institute of Environmental Protection studied six treatment plants and found that conventional mechanical-biological processes cannot effectively eliminate most medications. While pain relievers naproxen and ketoprofen were successfully removed, antidepressant fluoxetine, pain reliever diclofenac, and anti-seizure drug carbamazepine persisted—and sometimes even increased in concentration after treatment. The study, published in PLOS One on September 24, revealed that treatment plants in the study area released at least 40 metric tons of pharmaceuticals annually into rivers. These drugs remain biologically active even at extremely low concentrations, posing risks to fish and other aquatic organisms. The findings highlight a critical gap in current wastewater treatment technology and underscore the need for advanced pharmaceutical removal systems. (Eureka Alert)